Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 303

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease

SØRENSEN, JENS B., ANDERSEN, METTE K., HANSEN, HEINE H. · 1995 · Journal of Internal Medicine

Abstract

The first clinical case of a patient with the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) was presented by Schwartz et al. in 1957 (Am J Med 1957; 23: 529–42), describing two patients with lung cancer who developed hypo‐natraemia associated with continued urinary sodium loss. They postulated that the tumours led to the inappropriate release of antidiuretic hormone (ADH), later discovered to consist of arginine‐vasopressin (AVP). This suggestion was later confirmed in several studies. The clinical description of the syndrome has changed little since the original observation, and the cardinal findings of SIADH are as follows: (i) hyponatremia with corresponding hypo‐osmolality of the serum and extracellular fluid, (ii) continued renal excretion of sodium, (iii) absence of clinical evidence of fluid volume depletion, (iv) osmolality of the urine greater than that appropriate for the concomittant osmolality of the plasma, i.e. urine less than maximal diluted, and (v) normal function of kidneys, suprarenal glands and thyroid glands. Measurement of AVP in plasma is not a part of the definition of SIADH. SIADH may be caused by a variety of malignant tumours, but may also be caused by various other conditions, such as disorders involving the central nervous system, intrathoratic disorders such as infections, positive pressure ventilation and conditions with decrease in left atrial pressure. Also, a large number of pharmaceutical agents have been shown to produce SIADH, including a number of cytotoxic drugs such as vincristine, vinblastine, cisplatin, cyclophosphamide, and melphalan. A broad spectrum of malignant tumours has been reported to cause SIADH; however, most of these observations have been in case reports including very few patients. This includes a number of primary brain tumours, haematologic malignancies, intrathoracic non‐pulmonary cancers, skin tumours, gastrointestinal cancers, gynaecological cancer, breast‐and prostatic cancer, and sarcomas. Larger series of patients have revealed that SIADH occurs in 3% of patients with head and neck cancer (47 cases out of 1696 patients), in 0.7% of patients with non‐small‐cell lung cancer (three cases out of 427 patients), and in 15% of cases of small‐cell lung cancer (214 cases out of 1473 patients). The optimal therapy for SIADH is to treat the underlying malignant disease. If this is not possible, or if the disease has become refractory, other treatment methods are available such as water restriction, demeclocycline therapy, or, in severe cases, infusion of hypertonic saline together with furosemide during careful monitoring.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2796.1995.tb00907.x

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 303

Metadata

Authors
SØRENSEN, J. B., ANDERSEN, M. K., & HANSEN, H. H.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
1995-08
Volume
238
Issue
2
Pages
97-110
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2061328035
Cited by
303
References
34
FWCI
5.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. https://app.cochat.ai/papers/10.1111/j.1365-2796.1995.tb00907.x
The paper
SØRENSEN, J. B., ANDERSEN, M. K., & HANSEN, H. H. (1995). Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.1995.tb00907.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.